(Q35252410)

7 August 2017

1 reference

title

The microbiome in inflammatory bowel disease and its modulation as a therapeutic manoeuvre (English)

1 reference

inflammatory bowel diseases

7 August 2017

main subject

0 references

0 references

1

A L Hart

1 reference

7 August 2017

P Hendy

2

1 reference

7 August 2017

publication date

15 September 2014

1 reference

Proceedings of the Nutrition Society

7 August 2017

published in

1 reference

7 August 2017

volume

73

1 reference

7 August 2017

issue

4

1 reference

7 August 2017

page(s)

452-456

1 reference

Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Regulation of intestinal microbiota by the NLR protein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Molecular analysis of commensal host-microbial relationships in the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Review article: vitamin D and inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Techniques used to characterize the gut microbiota: a guide for the clinician.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Is there a role for fish oil in inflammatory bowel disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Gut Microbiota in Health and Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Immune responses to the microbiota at the intestinal mucosal surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Colonic health: fermentation and short chain fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Therapeutic implications of manipulating and mining the microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Review article: the association of diet with onset and relapse in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Early life factors and risk of inflammatory bowel disease in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Durable alteration of the colonic microbiota by the administration of donor fecal flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Duodenal infusion of donor feces for recurrent Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Low counts of Faecalibacterium prausnitzii in colitis microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Evaluation of rumen transfaunation after surgical correction of left-sided displacement of the abomasum in cows.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Microbial influences in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Meta-analysis: the effect and adverse events of Lactobacilli versus placebo in maintenance therapy for Crohn disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Unravelling the pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Saccharomyces boulardii does not prevent relapse of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

The environment within: how gut microbiota may influence metabolism and body composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Therapy of Metronidazole With Azathioprine to Prevent Postoperative Recurrence of Crohn's Disease: A Controlled Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Cesarean section and offspringʼs risk of inflammatory bowel disease: A national cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

Effect of oligofructose-enriched inulin (OF-IN) on bacterial composition and disease activity of patients with Crohn's disease: results from a double-blinded randomised controlled trial: Table 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

[Efficacy of exclusive enteral feeding as primary therapy for paediatric Crohn's disease]

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

7 January 2021

NOD2 prevents emergence of disease-predisposing microbiota

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

7 January 2021

Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

7 January 2021

Fecal microbiota transplantation and emerging applications

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

7 January 2021

Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

7 January 2021

Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

7 January 2021

Rifaximin-Extended Intestinal Release Induces Remission in Patients With Moderately Active Crohn's Disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

7 January 2021

Rapid and Noninvasive Metabonomic Characterization of Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

7 January 2021

Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

7 January 2021

CCFA microbial-host interactions workshop: highlights and key observations

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

7 January 2021

Enteral nutrition for maintenance of remission in Crohn's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

7 January 2021

The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001153

7 January 2021

10.1017/S0029665114001153

Identifiers

DOI

1 reference

7 August 2017

1 reference